Mawson Infrastructure Group Inc. — Director's Dealing 2017

Nov 27, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2017-11-16

Reporting Person: Zarachia Yaakov (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.001 per share	12283326	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant	$0.082	2020-11-16	Common Stock, par value $0.001 per share (6216869)		Direct